Allergic respiratory diseases encompass a range of conditions triggered by an exaggerated immune response to harmless airborne substances. Pollen, dust mites, pet dander, mold spores, and specific food items are among the prevalent allergens. Allergic rhinitis, commonly known as hay fever, is a prevalent allergic respiratory disease characterized by symptoms such as sneezing, nasal congestion, itching, and watery eyes. Asthma, another common allergic respiratory condition, involves inflammation of the airways, leading to wheezing, coughing, chest tightness, and difficulty breathing. Diagnosis typically involves medical history, physical examination, and allergy testing. Management strategies include allergen avoidance, pharmacotherapy (antihistamines, corticosteroids, bronchodilators), and allergen immunotherapy for long-term relief. Preventive measures include maintaining a clean living environment, using air purifiers, and practicing good respiratory hygiene. Allergic respiratory diseases significantly impact quality of life, and ongoing research aims to develop targeted therapies for better management and prevention.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain